Volume 1, Issue 1 (Spring and Summer 1997)                   Physiol Pharmacol 1997, 1(1): 1-8 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rashidipour A. Possible mechanism of tolerance to ketamine-induced blockade of cortical spreading depression. Physiol Pharmacol 1997; 1 (1) :1-8
URL: http://ppj.phypha.ir/article-1-299-en.html
Possible mechanism of tolerance to ketamine-induced blockade of cortical spreading depression
Ali Rashidipour
Abstract:   (20271 Views)
Ketamine (KET) induced blockade of cortical spreading depression (CSD) declines with repeated KET applications in a way suggesting the development of tolerance. Possible mechanism of this process was studied in 31 rats anestheized with pentobarbital. CSD was elicited by injection of 1µl of 5% KCl into cortex at 15 min intervals and monitored by recording the accompanying slow potential waves. After control recording, five injections of KET (50 mg/kg) were applied at 75 min intervals. The first KET injection elicited CSD blockade lasting for 30-45 min at the near and for 60- 75 min at the far electrode. The CSD blocking effect of subsequent injections gradually declined and was not recognizable after the fifth KET injection. MK-801 (2 & 5 mg/kg) injected to rats with marked KET tolerance 30 min after the last KET dose, failed to block CSD. Without KET pretreatment the same dosage of MK-801 induced CSD blockade lasting more than 1 h. KET tolerance did not prevent local CSD blockade in cortical area superfused with 10 mol/l AP5. It is concluded that repeated applications of KET may induce some conformational changes at binding site(s) in the N-methyl-D-aspartate (NMDA) controlled channels shared by both KET and MK-801
Keywords: Spreading depression; Cerebral cortex; Ketamine; AP5; N-Methyl-D-Aspartate receptor; MK-801
     
Type of Manuscript: Experimental research article |
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.